Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
June 2009
June 2
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
Genzyme Completes Transaction with Bayer HealthCare
TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution
FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes in Diagnosis and Treatment
Drug Industry Marketing Direct to Consumers and Doctors May Lead to Prescription Overuse
PharmaLive.com Launches New Report on DTC Ad Spending
Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
Bio-Imaging Technologies and etrials Worldwide Merger Agreement Terminated
June 3
Advaxis Receives FDA Response to Orphan Drug Filing
FDA Forms Transparency Task Force
Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents
Pfizer Announces Completion Of European Debt Offering
FDA MedWatch - Propylthiouracil (PTU) associated with risk of serious liver injury, including liver failure and death
Genmab Announces Partial Clinical Hold on Zalutumumab Studies
June 4
Adolor Corporation Announces Staff Reductions and Restructuring
FDA Warns About Serious Liver Injury Associated With Anti-Thyroid Drug
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of Trilipix (fenofibric acid)
Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
June 8
Aileron Therapeutics Closes $40 Million Series D Financing
Jean-Philippe Santoni Appointed Senior Vice President, Industrial Development and Innovation
EU-wide Recall of Raptiva (efalizumab) to be Initiated
Sanofi-aventis to Purchase Diabel Manufacturing Facility in Frankfurt to Strengthen Insulin Production Capacities
Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough
Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire GL Biochem (Shanghai) Ltd
June 9
CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
House Committee on Energy and Commerce Chairman Waxman Writes President Obama Regarding Generic Biologics
Progenics Provides Update on Hepatitis C Program
Merck & Co.: Corporations Need to Tackle Global Corruption as Strategic CSR Effort
GSK and Shenzhen Neptunus Create New Alliance to Develop and Manufacture Influenza Vaccines in China
NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
June 11
Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.
FTC Releases Report on ?Follow-on Biologic Drug Competition?
Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.2 Percent First Quarter 2009
Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem
June 12
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor
ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound
Oscient Pharmaceuticals Discontinues Sales Force Promotion for Antara and Factive
Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
61% of American Adults Look Online for Health Information
June 15
June 16
FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
FDA Warns Web Sites Against Marketing Fraudulent H1N1 Flu Virus Claims
Eli Lilly and Company Announces New Drug Discovery Initiative
Genzyme Temporarily Interrupts Production at Allston Plant
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
June 17
June 18
June 19
June 22
Merck & Co., Inc. Statement on Medicare Part D Assistance
Vical Receives Milestone Payment From Merck & Co., Inc.
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza
Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
PhRMA Statement on the Health Care Reform Agreement
Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
June 23
Merck Prices $4.25 Billion Debt Offering
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
Deductibility of Prescription Drug Ads May Be Under Threat
GSK and Chroma Therapeutics Form Alliance to Develop Novel Macrophage-Targeted Drugs
Mass. AG Martha Coakley?s Office Files Complaint Against Drug Manufacturer Wyeth
PharmaLive.com Launches New Pipeline Report
June 24
Medifacts Acquires Spacelabs Healthcare Clinical Trials Services Division
Takeda Announces Completion of Tender Offer for All Outstanding Shares of IDM Pharma, Inc.
Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries
Teva Pharmaceuticals Issues Statement in Response to Federal Trade Commission Claims on Patent Settlements
June 25
Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
Novo Growth Equity Expands Team, and Will Invest Up to $200M Per Year
Sen. Grassley Seeks Information About Medical School Policies for Disclosure of Financial Ties
Uluru Discussions to Acquire York Pharma, plc Are Currently Terminated
ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
June 26
U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.
Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
CHMP Issue Opinions
Announcement of Establishment of a Holding Company in the U.S.
Novo Nordisk Reaches Settlement With the Danish Authorities Regarding Oil-for-Food Activities
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
June 28
June 29
A Side Effect of Michael Jackson’s Tragic Death – Consumer Health Education
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
Simponi (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
ChemGenex to Seek Voluntary De-Listing From NASDAQ and to Restructure Board to Reflect Compliance Needs
Christian Lajoux Appointed President for sanofi-aventis in France
UCB Brings Neupro Back to All Patients in Europe
FDA Sends Romark Laboratories Warning Letter About Statements on Alinia Sales
FDA Reviews Mailer from Millennium Pharmaceuticals for Velcade
June 30
Sanofi-Aventis Presents New R&D Model Project to Boost Innovation
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
UCB (BE) - UCB and Biogen Idec Discontinue Phase II Clinical Trial of CDP323
Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
